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Objective: We sought to identify patients at risk of incomplete transvaginal oocyte retrieval, develop a
risk assessment formula to identify patients who would beneﬁt from a transabdominal approach, and
compare complication and pregnancy rates between these two approaches.
Materials and Methods: In this retrospective case control study in a private in vitro fertilization center, 95
cases of women undergoing transabdominal follicular aspiration for oocyte retrieval (15 transabdominal
only and 80 transabdominal and vaginal combined) were compared with 278 controls of women un-
dergoing the transvaginal aspiration only. Transabdominal oocyte retrieval was performed when one or
more ovaries could not be retrieved via the transvaginal approach. Main study outcomes included need
for transabdominal retrieval, pregnancy rates, and complications.
Results: A risk assessment scoring system was developed as follows: difﬁculty seeing ovaries on ultra-
sound (þ4), history of pelvic surgery (þ3), and body mass index of 30 kg/m2 or greater (þ2). With a
cutoff score of 4 or greater, the overall sensitivity is 75%, speciﬁcity is 80%, positive predictive value is
57%, and negative predictive value is 90%. No statistically signiﬁcant differences were found for preg-
nancy rates or complications.
Conclusion: The transabdominal approach is an alternative option that would increase the total number
of oocytes retrieved with no statistical difference in complication or pregnancy rates. We also developed
a scoring system that can serve as a useful screening tool for identifying women at increased risk of
transabdominal oocyte retrieval.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Oocyte retrieval is achieved almost exclusively by the trans-
vaginal ultrasound-guided (TVUS) follicle aspiration method [1,2].
Before TVUS-guided aspiration, oocytes were aspirated under
direct visual guidance via laparoscopy or via transabdominal
approach [3].ical Center, Department of
ad Turnpike, East Meadow,
Roman-Rodriguez).
bstetrics & Gynecology. PublishedSeveral studies have compared laparoscopic [4], trans-
abdominal, and transvaginal follicular puncture and aspiration.
Transvaginal follicular aspiration is usually preferred due to its
shorter operation time and less invasive nature, but the trans-
abdominal ultrasound-guided (TAUS-guided) follicular aspiration is
considered a safe and efﬁcacious procedure in women with ovaries
inaccessible by TVUS [5]. The TAUS oocyte retrieval method is still
used and published in case reports in women with radical hyster-
ectomies, transposed ovaries [6,7], and Müllerian agenesis [8e10].
There may be a larger role presently for an increased utiliza-
tion of transabdominal retrievals due to an increasing body mass
index (BMI) in the U.S. population [11]. As the BMI increases,
there is an increase in anatomic distortion, which contributes toby Elsevier Taiwan LLC. All rights reserved.
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and accessing ovaries from the transvaginal approach [12]. We
have developed a risk assessment scoring system to identify
women undergoing in vitro fertilization (IVF) who are at risk of
requiring TAUS as compared with TVUS oocyte retrieval. The
purpose of this study is to determine factors requiring TAUS
oocyte retrieval due to an inability to retrieve all oocytes trans-
vaginally and evaluate its complications and effects on pregnancy
rates. We wanted to evaluate if an increased BMI would be a risk
factor, making it less likely to retrieve all oocytes by the tradi-
tional transvaginal aspiration approach. We evaluated additional
risk factors (ﬁbroids, prior surgery, infection, and endometriosis)
to see whether these factors show a difference in the ability to
retrieve oocytes and have an impact on pregnancy rates or
complications.Materials and methods
Participants
This is a retrospective case control study of women undergoing
IVF who had underwent either TVUS or TAUS oocyte retrieval at a
private infertility center. Institutional Review Board approval from
North Shore-Long Island Jewish Health System was obtained. At
retrieval, an attempt was made to access the ovaries transvaginally
but if TVUS aspiration was not possible for one or both ovaries,
transabdominal aspiration was performed to maximize the num-
ber of oocytes retrieved. Prior to proceeding with TAUS retrieval,
the following steps were performed in an attempt to access the
ovaries transvaginally: (1) transabdominal pressure, (2) cervical
traction, and (3) reverse Trendelenburg. If these steps failed to
provide transvaginal access to one or both ovaries, then a trans-
abdominal approach was attempted. Cases (the transabdominal
group) included patients with oocyte retrieval using TAUS exclu-
sively or oocyte retrieval using a combination of TAUS and TVUS.
Combined retrievals were deﬁned as cases inwhich TVUS retrieval
was achieved in one ovary but only TAUS in the contralateral ovary.
Controls were selected as the subsequent three transvaginal
oocyte retrievals. A total of 373 cases were obtained for this study.
Inclusion/exclusion criteriawere applied to both groups. The study
period was from January 18, 2012, to October 9, 2013.Inclusion criteria
Inclusion criteria were patients seeking fertility who had oocyte
retrievals. Data were collected in a 3:1 ratio where 278 (74.5%)
underwent vaginal oocyte retrieval, and 95 (25.5%) underwent
transabdominal oocyte retrieval. TAUS oocyte retrieval included 15
patients who had TAUS oocyte retrieval exclusively and 80 patients
who had combined transvaginal/transabdominal oocyte retrieval.
Cases within each group were randomly assigned to be in the
derivation sample (n ¼ 186) for the validation sample. Derivation
was used to identify factors that differentiated transabdominal
from vaginal cases and build a scale. The validation sample was
then used to examine the utility of the scale and calculate diag-
nostic efﬁciency scores. These procedures are consistent with
those utilized by other researchers attempting to build detections
scales [13].Exclusion criteria
Patients who had incomplete documentation were excluded
from the study.Variables of interest
Data were collected using a standardized form to review
medical records. For each case, we recorded whether the patient
had required TAUS oocyte retrieval or not. Other variables
included BMI and history with the following considerations:
laparoscopic surgery, history of laparotomy or pelvic surgery
including cesarean section and myomectomies, presence of leio-
myomas, polycystic ovarian syndrome (PCOS), ovaries difﬁcult to
see with TVUS, parity, sexually transmitted disease including
pelvic inﬂammatory disease and tubo-ovarian abscesses, ectopic
pregnancy, and endometriosis. We also compared pregnancy rates
and time of procedure. Difﬁcult to see ovaries with TVUS was
deﬁned as the inability to see one or both ovaries using a TVUS
after the following steps: (1) transabdominal pressure, (2) cervical
traction, and (3) reverse Trendelenburg. Complications were
deﬁned as excessive bleeding requiring more than vaginal sutures
for hemostasis including blood transfusion, infections, or hospital
admissions. Postoperative pain in both groups was also measured
as follows: patients with “mild pain” were deﬁned as those
receiving one to two tablets of acetaminophen (500 mg) in the
postoperative period and patients with “moderate to severe pain”
were deﬁned as those receiving one to two doses of ketorolac
(30 mg) intravenous push.Statistical analysis
Categorical variables for patients who received TAUS procedures
were compared with those of patients who underwent TVUS
retrieval procedures using Pearson Chi-square tests (c2). Chi-
square tests were used to examine whether there were differ-
ences in pregnancy rates and pain status across the TVUS and TAUS
groups. We used Student t tests to compare dimensional variables
(e.g., age). For variables that differed signiﬁcantly between groups,
we calculated sensitivity (Se), speciﬁcity (Sp), positive likelihood
ratio (LRþ), and negative likelihood ratio (LRe).
We conducted multiple logistic regression analysis, with a for-
ward stepwise procedure, to identify an optimal model for
detecting individuals requiring transabdominal procedures [14].
Only variables that differed signiﬁcantly across patient groups in
the univariate analyses were utilized in the multiple logistic
regression analysis. This approach has been employed in similar
studies [15]. Based on the ﬁndings from the multiple logistic
regression analysis, we weighted the value of each variable. These
weighted scores were summed to create a scale score. We then
calculated Se, Sp, LRþ, LRe, odds ratio (OR), positive predictive
value (PPV), and negative predictive value (NPV) for multiple cutoff
scores. Because prevalence rates for transabdominal procedures
may vary across populations, diagnostic efﬁciency scores for mul-
tiple cutoff scores were calculated and reported. This allows clini-
cians to adjust risk thresholds based on speciﬁc needs and
prevalence rates for various populations.Results
Demographics and complications
The average age (in years) for the study sample was 37.60
(standard deviation 5.15). Regarding ethnic background, 225
(59.3%) cases were identiﬁed as white/Caucasian, 75 (19.8%) for
black/African American, 50 (13.2%) Hispanic/Hispanic American,
18 (4.7) Asian/Asian American, and 11 (2.9%) “others.” Of these
cases, 278 (74.5%) underwent TVUS oocyte retrieval and 95
(25.5%) underwent TAUS oocyte retrieval. The TVUS group had an
Table 1
Diagnostic performance characteristics for variables signiﬁcantly differing across groups in the derivation sample.
Derivation
sample
n ()
Vaginal with
condition
n ()
Transabdominal with
condition
n ()
c2 p Se () SP () LRþ LRe
No. of patients 186 (100) 139 (74.3) 47 (25.7)
Obese a 69 (37.3) 40 (29.0) 29 (61.7) 15.05 <0.001 62 71 2.13 1.85
History of laparoscopic surgery 40 (21.5) 25 (18) 15 (31.9) 4.04 0.05 32 82 1.77 1.21
History of pelvic laparotomy including
cesarean section and myomectomies
70 (37.6) 42 (30.2) 28 (59.6) 12.9 <0.001 60 70 1.97 1.72
Presence of leiomyoma 54 (29) 35 (25.2) 19 (40.4) 3.96 0.05 40 75 1.61 1.26
PCOS 12 (6.5) 6 (4.3) 6 (12.8) 4.12 0.04 12 96 2.96 1.1
Difﬁculty seeing ovary on transvaginal
ultrasound
40 (21.5) 16 (11.5) 24 (51.1) 32.55 <0.001 0.51 0.89 4.44 1.81
LRþ ¼ positive likelihood ratio; LRe ¼ negative likelihood ratio; PCOS ¼ polycystic ovarian syndrome; Se ¼ sensitivity; Sp ¼ speciﬁcity; eta ¼ partial regression coefﬁcient.
a Obese indicates patients with BMI 30 kg/m2.
Difﬁculty seeing the ovaries on ultrasound Yes (4 points) No (0 points)
History of Laparotomy pelvic surgery Yes (3 points) No (0 points)
BMI in obese range (BMI  30 kg/m2) Yes (2 points) No (0 points)
Total points _________
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had an average of 28.2 minutes.
No serious intraoperative complications were observed. In
the TVUS group, two patients required vaginal sutures for he-
mostasis, whereas in the TAUS only one patient required sutures.
Hospital admission and infections requiring antibiotics were not
observed in either group. With regard to pain, 39.4% of patients
in the TAUS group experienced mild pain, whereas only 20.4% of
those in the TVUS group experienced mild pain. This difference
was highly signiﬁcant (c2 ¼ 13.41, df ¼ 1; p < 0.001); 42.5% of
the patients in the TVUS group experienced moderate to severe
pain and 51.1% of those in the TAUS group experienced moderate
to severe pain, but this difference was not statistically
signiﬁcant.Derivation sample results
For the derivation sample, we compared pregnancy rates be-
tween the TVUS retrieval group and the TAUS retrieval group
using Chi-square test. Data on derivation sample comparing TAUS
with TVUS for pregnancy rates are as follows: c2 ¼ 0.02, p ¼ 0.88.
Groups did not differ signiﬁcantly on pregnancy rates. Regarding
the oocyte retrieval method, 139 (74.7%) underwent TVUS
retrieval and 47 (25.3%) required TAUS procedures in the deri-
vation sample. Data from univariate analyses are reported in
Table 1. Risks for requiring TAUS procedures were not associated
with age, being underweight (BMI < 18.5 kg/m2), parity, a history
of sexually transmitted infection or pelvic inﬂammatory disease,
or a history of an ectopic pregnancy. Although a history of
endometriosis was closely associated with requiring TAUS pro-
cedures, it did not achieve statistical signiﬁcance (c2 ¼ 2.99,
df ¼ 1, p ¼ 0.08).
The variables listed in Table 1 were entered into a multiple lo-
gistic regression using procedure (TVUS vs. TAUS) as the dependent
variable. Results for the logistic regression are reported in Table 2.
The following three variables were entered into the model as sig-
niﬁcant predictors: difﬁculty seeing ovaries on ultrasound, being
obese (BMI 30 kg/m2), and a history of pelvic laparotomy surgery.
A scale score was calculated using the Wald ratio to weigh each
variable from the logistic regression. This culminated in the
following formula: score¼ (obese  2) þ (history of pelvic
surgery  3) þ (ovaries difﬁcult to see on ultrasound  4). The
receiver-operating characteristic (ROC) curve for this score is pre-
sented in Figure 1. The area under the ROC curve (AUC) was 0.80,
which falls into the lower portion of the “good” range [16]. A
simpler way to look at the formula would beValidation sample results
For the validation sample, we compared pregnancy rates be-
tween the TVUS retrieval and TAUS retrieval groups using Pearson
Chi-square test. The validation sample compares the two groups for
pregnancy rates (c2 ¼ 0.75, p ¼ 0.39). Consistent with the deriva-
tion sample, the two groups did not differ signiﬁcantly on preg-
nancy rates in the validation sample as well. The validation sample
was used to examine the diagnostic utility of various cutoff scores
for the scale. In the validation sample, 139 (74.3%) cases received
vaginal retrieval and 48 (25.7%) cases required TAUS retrieval. Of
note, BMI data were missing for three of the TVUS retrieval cases in
the validation sample. Thus, we were only able to calculate scale
scores for 136 of the 139 TVUS retrieval cases. Diagnostic efﬁciency
statistics for the validation sample are reported in Table 3. Diag-
nostic efﬁciency statistics are reported for multiple cutoff scores to
allow clinicians to adjust risk tolerance as needed. A cutoff score of
four or greater appears to balance sensitivity and speciﬁcity needs.
The ROC curve for the validation sample is depicted in Figure 2. The
AUC for the validation sample was highly similar to that of the
derivation sample (ROCeAUC ¼ 0.79).Comments
Risk assessment score
TVUS-guided follicular aspiration has been the standard of care
for IVF procedures since studies have proven its efﬁcacy and ease of
use. However, some clinical situations have made TVUS oocyte
retrieval an ineffectivemethod for patients with certain risk factors,
such as increased BMI and displacement of ovaries. These patients
may beneﬁt from the use of TAUS oocyte retrieval to maximize the
numbers of oocytes retrieved. Our retrospective study sought to
determine the factors that would require the use of TAUS over TVUS
oocyte retrieval. In the derivation sample, we found that women
undergoing TAUS were more likely to be obese, have a history of
laparoscopic or pelvic laparotomy surgery, and have ﬁbroids and
PCOS (Table 1). The most signiﬁcant risk factor was the difﬁculty to
see the ovaries on TVUS during follicular monitoring. After entering
these variables into a multiple regression analysis, three variables
came out as signiﬁcant predictors: difﬁculty seeing ovaries on
Table 2
Multiple logistic regression values for variables entered into the ﬁnal model.
Wald aOR 95% CI
Difﬁculty seeing ovary on transvaginal
ultrasound
22.67 0.11 0.05e0.28
Obese a 9.66 0.28 0.13e0.63
History of pelvic laparotomy including
cesarean section and myomectomies
14.99 0.19 0.08e0.44
95% CI ¼ 95% conﬁdence interval; aOR ¼ adjusted odds ratio.
a Obese indicates patients with BMI 30 kg/m2.
Figure 1. Receiver-operating characteristics (ROC)
Table 3
Diagnostic efﬁciency scores for various scale cutoffs in the validation sample.
Cutoff score a Se
(%)
Sp
(%)
LRþ LRe PPV
(%)
NPV
(%)
OR
2 87 46 1.63 3.63 36 91 5.90
3 81 58 1.93 3.03 40 90 5.86
4 75 80 3.75 3.14 57 90 11.78
5 64 83 3.77 2.3 57 87 8.67
6 53 90 5.17 1.92 64 85 9.90
7 28 93 4.18 1.29 59 79 5.40
LRþ ¼ positive likelihood ratio; LRe ¼ negative likelihood ratio; NPV ¼ negative
predictive value; OR ¼ odds ratio; PPV ¼ positive predictive value; Se ¼ sensitivity;
Sp ¼ speciﬁcity.
a Score is the sum of difﬁculty seeing ovaries on ultrasound (þ4), a history of
pelvic surgery (þ3) and BMI  30 kg/m2dobese (þ2).
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laparotomy surgery (Table 2).
To stratify the probability of patients that may need to undergo
TAUS, a risk assessment scoring system was developed based on
these signiﬁcant variables using the following formula: difﬁculty
seeing ovaries on ultrasound (þ4), a history of pelvic surgery (þ3),
and BMI  30 kg/m2 (obese) (þ2). With a cutoff score of 4 or
greater, the overall sensitivity is 75%, speciﬁcity is 80%, PPV is 57%,
and NPV is 90% (Table 3). A cutoff score of four or greater appears tocurve for scale score in the derivation sample.balance sensitivity and speciﬁcity needs. The ROC curve for the
validation sample (ROCeAUC ¼ 0.79) is depicted in Figure 2 and
this is highly similar to that of the derivation sample in Figure 1
(ROCeAUC ¼ 0.80). When the population base rate is low, the
predictive power of a negative test result will be more than that of a
positive test result. In addition, in cases with a rare condition
having a low prevalence, a positive test result is most likely to be
incorrect and the PPV will be artiﬁcially deﬂated [17]; however, the
ORwill not be affected [18]. This is important for understanding the
current results. The suggested cutoff produced reasonable sensi-
tivity, speciﬁcity, NPV, and OR; PPV is, however, low. Low PPV is due
in large part to the fact that the event (i.e., TAUS) occurs infre-
quently. Thus, while the screening test has adequate to strong test
characteristics overall, PPV is necessarily limited. It is important to
appreciate the meaning of this pattern of results. Low PPV is not
Figure 2. Receiver-operating characteristics (ROC) curve for the validation sample.
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it is best to consider the PPV in relation to the other diagnostic
indicators to appreciate implications for interpreting results.
The scale's strong OR, speciﬁcity, and NPV suggest that the
approach will yield few false negatives. For example, NPVs suggest
that a woman scoring below the suggested cutoff has a 90% chance
of not requiring TAUS oocyte retrieval. Thus, clinicians can be fairly
conﬁdent that a woman scoring below the cutoff will not require
TAUS. By contrast, scores above the cutoff do not guarantee that
TAUS will be required. In fact, in the present sample, only 57% of
women scoring above the suggested cutoff required TAUS oocyte
retrieval (following attempted TVUS oocyte retrieval). Thus, a
positive score indicates an increase in risk above the observed
prevalence rate of 25% but it probably does not indicate that TAUS is
needed with certainty. As such, clinicians are likely, except in
exceptional circumstances, to proceed with TVUS oocyte retrieval
procedure even in women scoring above the cutoff. Nonetheless,
information from the screening test may inform how the clinician
characterizes the probability of success, counsels, and proactively
informs that patient regarding other options (should TVUS oocyte
retrieval fail).
We believe that this novel scoring system can serve as a useful
screening tool for identifying and counseling women undergoing
IVF who are at an increased risk of TAUS oocyte retrieval. The scale
requires very little in terms of clinical burden and scores can be
calculated using data routinely collected as part of the overallprocedure. From a clinical standpoint, with good OR, this infor-
mation can be used to help physicians prepare preoperative pa-
tients accurately by informing patients with a low risk score that
they will most likely require only TVUS. When counseling women
with scores below the cutoff, physicians can feel conﬁdent that
TAUS oocyte retrieval will not be needed. However, when coun-
selingwomenwith scores above the cutoff, clinicians will dowell to
be a bit more cautious in terms of framing risk for TAUS. However,
clinicians should not misconstrue the present ﬁndings as suggest-
ing that a score above the cutoff guarantees that a woman will
deﬁnitely need TAUS nor does a score above the cutoff suggests that
TVUS oocyte retrieval procedures should not be utilized. Instead,
scores above the cutoff suggest that clinicians be considerate in
how they describe the likelihood of needing TAUS to maximize
oocyte retrieval.
We acknowledge that our cutoff score is the same as what dif-
ﬁculty seeing ovaries is worth. Thus, when this indicator is present,
the patient automatically “screens in” emphasizing its potential
importance. Patients with other factors (obesity and history of
laparotomy) will have a higher score, and therefore a greater risk of
undergoing TAUS tomaximize the number of oocytes retrieved. The
difference between using the single indicator of “difﬁcult to see
ovaries on TVUS” and the scale could be the level of conﬁdence. As
indicators accrue, there is a cumulative increase in the patient's risk
andwhenmaking clinical decisions, our conﬁdence should increase
as more indicators are present.
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have proven its efﬁcacy and safety in follicular aspiration. In a study
done to test TAUS, it was demonstrated that TAUS-guided follicular
aspiration is safe and efﬁcient in women with signiﬁcant ovarian
displacement compared with transvaginal aspiration in women
with normally positioned ovaries [5]. Given the demonstrated
safety of this procedure, a risk assessment score to guide the use of
TAUS follicular aspiration is of particular importance in our society
today and should be considered to maximize the numbers of oo-
cytes retrieved. It is known that BMI is steadily increasing nation-
wide, which is affecting fertility and assisted reproductive
technology outcomes [20]. In a study on obese pregnant women, it
was shown that increased adipose tissue slows down the returning
signal during ultrasound, causing loss of image quality and possibly
explaining why ovaries might be difﬁcult to see in obese patients
[12]. Studies have also reported difﬁculty seeing ovaries in patients
with PCOS secondary to central displacement of fat that occurs with
androgen excess and insulin resistance [21]. In our study, PCOS was
statistically signiﬁcant (p ¼ 0.04) in the derivation sample of the
TAUS retrieval group. However, we believe that increased BMI in
these patients was the main risk factor that may have contributed
to the use of TAUS as the patients with PCOS also had a BMI sug-
gesting obesity.
Pregnancy rates
Our study revealed no statistically signiﬁcant difference be-
tween TAUS and TVUS procedures when comparing pregnancy
rates. These results are important because TAUS oocyte retrieval
will provide an alternative to retrieving and maximizing oocytes
retrieval for cases in which transvaginal access is difﬁcult without
affecting pregnancy rates. Previous studies reported that cases of
TAUS aspiration had slightly fewer oocytes retrieved, but no sta-
tistically signiﬁcant differences were found for damaged oocytes,
fertilization rates, embryo number and quality, or pregnancy rates
[5]. These previous reports are consistent with our ﬁndings because
no difference in pregnancy rates was seen in both groups. Knowing
that pregnancy rates are not affected, the physician can counsel the
patient on this modality and reassure her that the likelihood of
pregnancy will probably be the same as for TVUS follicular
aspirations.
Complications and safety
In terms of intraoperative complications and safety, there was
no statistical difference in complications associated with TAUS
when compared with TVUS. Postoperative moderate/severe pain
medication had no statistical signiﬁcance in both groups and there
were no hospital admissions or infections requiring antibiotics.
These ﬁndings are consistent with a recent study that reported
that TAUS appears to be a safe alternative to TVUS with minimal
complications [5]. A prior study reported abdominal complica-
tions following ultrasonically guided percutaneous transvesical
collection of oocytes for IVF. Among the reported complications
were a higher incidence of abdominal pain, exacerbation of pre-
vious pelvic inﬂammatory disease, mild hemoperitoneum, urinary
tract infections, and transient macroscopic hematuria after the
procedure [22]. In our study, we did not see these complications.
In the TVUS group, only two patients required vaginal sutures for
hemostasis, whereas in the TAUS combined group only one pa-
tient required vaginal sutures as that ovary was retrieved trans-
vaginally. In addition, patients in the TAUS group did require more
pain management for the diagnosis of mild pain, which was
adequately controlled with acetaminophen. In addition, patients
undergoing TAUS follicular aspiration were under anesthesia foran average of 8 minutes longer than those undergoing the TVUS
technique. This along with the fact that most TAUS techniques
were combined procedures, because the ﬁrst attempts were to
retrieve transvaginally, may account for the slight increase in pain
management requirements for the mild pain group as well as the
increase in surgery time. Despite this fact, the patients undergoing
TAUS in our study did not experience any of the other complica-
tions described in previous studies. No blood transfusion, antibi-
otics, or hospital admissions were needed in our patients. These
ﬁndings are signiﬁcant because many physicians turn away from
TAUS due to concerns that these potential complications may
outweigh the risk of not retrieving all oocytes from a patient
during an IVF cycle. This study shows no signiﬁcant statistical
difference in complications with TAUS when compared with
TVUS.
Clinically, this can reassure physicians to have this additional
tool to maximize oocytes retrieval without increasing morbidity to
the patient. Implementing a structured assessment tool to predict
the use of TAUS can indicate a patient at risk of undergoing TAUS to
maximize the total number of oocyte retrieved. By proceeding
directly to TAUS in patients at high risk, we may also decrease the
total operating time and avoid an unsuccessful transvaginal
approach ﬁrst.Limitations
Although we attempted to minimize confounding factors, our
studywas notwithout limitations. Pregnancy rates were inﬂuenced
by a variety of patient risk factors, and wewere unable to control all
of them. For example, both PCOS and BMI were statistically sig-
niﬁcant in the derivation sample of the TAUS retrieval group.
However, we believe that the increased BMI in these patients was
themain risk factor that contributed to the use of TAUS. In addition,
live birth rates could not be determined due to pending deliveries.Conclusion
In conclusion, TAUS-guided follicular aspiration can augment
the total number of oocyte retrieved over the standard transvaginal
method, especially in patients with obese BMIs, history of pelvic
surgeries, or difﬁculties with visualizing the ovaries during IVF
cycle stimulation. With this novel and simple scoring system, we
can have a useful screening tool for identifying and counseling IVF
women at increased risk of transabdominal oocyte retrieval when a
score is greater than or equal to 4 points with a sensitivity of 75%,
speciﬁcity of 80%, PPV of 57%, and NPV of 90%. From a clinical
standpoint, this information can be used to help physicians prepare
preoperative patients with a low risk score by informing them that
they will most likely require only TVUS. As previous literature
supports, TAUS oocyte retrieval is a safe and effective way to
retrieve more oocytes when transvaginal procedure is not possible.
In regards to pregnancy rates, there is no statistical difference noted
between the two procedures. Our novel scoring systemwill permit
physicians to identify patients who are likely to undergo TAUS and
counsel them prior to the procedure. TAUS oocyte retrieval pro-
vides a safe and effective complement to retrieving more oocytes
for cases with difﬁcult transvaginal access and has no difference in
complications and pregnancy rates.Conﬂicts of interest
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